First clinical trial of reformulated epileptic drug to treat medically refractory epilepsy

Written By Distill

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.

UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS, April 3, 2019

Read Full Article

Distill https://www.distillagency.com
Previous

Cerebral Therapeutics™ Strengthens Clinical Development Leadership with Strategic Appointments
Next

Cerebral Therapeutics™ Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy